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Vaginal Fibroblastic Cells from 
Women with Pelvic Organ Prolapse 
Produce Matrices with Increased 
Stiffness and Collagen Content
Alejandra M. Ruiz-Zapata1,†, Manon H. Kerkhof1, Samaneh Ghazanfari1, Behrouz Zandieh-
Doulabi2, Reinout Stoop3, Theo H. Smit1 & Marco N. Helder1
Pelvic organ prolapse (POP) is characterised by the weakening of the pelvic floor support tissues, and 
often by subsequent prolapse of the bladder outside the body, i.e. cystocele. The bladder is kept in 
place by the anterior vaginal wall which consists of a dense extracellular matrix rich in collagen content 
that is maintained and remodelled by fibroblastic cells, i.e. fibroblasts and myofibroblasts. Since 
altered matrix production influences tissue quality, and myofibroblasts are involved in normal and 
pathological soft tissue repair processes, we evaluated matrix production of cells derived from pre- and 
post-menopausal POP and non-POP control anterior vaginal wall tissues. Results showed that cells 
from postmenopausal POP women deposited matrices with high percentage of collagen fibres with less 
anisotropic orientation and increased stiffness than those produced by controls. There was a transient 
increase in myofibroblastic phenotype that was lost after the peak of tissue remodelling. In conclusion, 
affected fibroblasts from postmenopausal prolapsed tissues produced altered matrices in vitro 
compared to controls. Such aberrant altered matrix production does not appear to be a consequence of 
abnormal phenotypical changes towards the myofibroblastic lineage.
Pelvic organ prolapse (POP) is characterised by the weakening of the pelvic floor supportive tissues, with subse-
quent prolapse of the uterus, rectum and/or most commonly the bladder outside the body1–3. POP affects almost 
50% of postmenopausal women causing them to suffer chronic pain, urinary incontinence, and voiding and 
sexual dysfunctions1,2. There is a strong genetic component in some women affected with prolapse4 but environ-
mental factors related to increased abdominal pressure, such as parity, physiological ageing and obesity, also seem 
to play an important role in the development of the disease in many patients5.
In healthy women the bladder is kept in place by the connective-tissue layer of the anterior vaginal wall which 
is a dense extracellular matrix (ECM) with relatively few cells. The ECM obtains its strength from the fibrillar 
proteins (collagen I, III, V and elastin)6 and is produced and maintained by fibroblastic cells, i.e. fibroblasts and 
myofibroblasts. Fibroblastic cells remodel their surrounding matrix and maintain tissue homeostasis by produc-
ing anabolic molecules and catabolic enzymes such as the matrix metalloproteinases (MMPs). Matrix production 
and remodelling affect the composition and mechanical properties of the surrounding tissues whose integrity 
depends on a balance between ECM synthesis and degradation.
In prolapsed tissues however, this balance seems to be lost as studies indicate that the metabolism of collagen 
and elastin is altered7. In patients with cystocele, the prolapsed anterior vaginal wall tissues were shown to have: 
disorganized collagen and elastin fibres8; increased enzymatic activity9–11; altered elastin12,13 and collagen con-
tent9,10,14–16; altered collagen cross-linking9,17; and increased stiffness16,18–20. Fibroblastic cells derived from pro-
lapsed anterior vaginal wall tissues are also affected as their contractile capacities are lower than non-prolapsed 
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cells21–23, their mechano-responses are altered23,24, and they seem to have lower responses to transforming growth 
factor-β (TGF-β )25, a recognized activator of myofibroblast differentiation. Prolapse therefore affects tissue com-
position, tissue mechanical properties and cell behaviour. Nevertheless it is not known if prolapse also affects the 
capacity of the cells to produce and remodel the ECM. Moreover, fibrillar collagens are the main components of 
the vaginal ECM, they provide strength to the tissues6, and they are involved in fibroblast to myofibroblast differ-
entiation26, which is a process involved in healthy and pathological soft tissue repair and remodelling and has not 
been studied in the context of POP. In the present study we hypothesized that prolapse affects fibroblastic cells 
collagen matrix production and remodelling. To test our hypothesis we evaluated the in vitro matrix production 
of primary cells derived from vaginal tissues from pre- and post-menopausal women with and without POP. The 
quantity and quality of the deposited matrix were tested for total protein content, total fibrillar collagen content 
and collagen cross-linking. In particular, collagen I fibre orientation was visualized and quantified. The mechan-
ical properties of the matrices were measured using micro-indentation. We also followed cellular differentiation 
towards the myofibroblastic phenotype using α -smooth muscle actin (α -SMA) which was detected by western 
immunoblotting.
Results
Anterior vaginal wall cells from patients with prolapse deposit extracellular matrices with less 
protein content than control cells, but with high collagen content. The primary aim of this study 
was to find out if cells isolated from anterior vaginal wall tissues from women with cystocele deposit different 
extracellular matrices (ECM) in vitro than cells derived from controls (non-prolapsed tissues). The cells were 
cultured for five weeks in the presence of vitamin C, and matrix production was tested at 0, 1, 3, 4 and 5 weeks. 
Results show that matrix production from vaginal cells derived from prolapsed tissues was lower than those from 
controls, however with high collagen content. Matrix deposition increased overtime with peak values at week 
3 for controls, and at week 4 for POP matrices (Fig. 1A). The total amount of protein was lower in POP than in 
control matrices only at week 3 (Fig. 1A) but the collagen content was similar (Fig. 1B). The percentage of collagen 
fibres in matrices produced by cells from postmenopausal women with prolapse was higher than in the matrices 
deposited by cells from controls (Fig. 1C). The same trend was seen in matrices from premenopausal women with 
POP (Fig. 1C).
Fibroblastic cells from women with prolapse produced stiffer matrices than controls. Pelvic 
organ prolapse has been shown to affect cell behaviour in vitro21–24. To investigate if prolapse also affects the 
quality of the matrix produced by vaginal cells we tested the surface micro-stiffness of matrices deposited after 5 
weeks of culture. We tested the matrices using a micro-indentor with a soft cantilever on top of a ferruled optical 
fibre. Results showed that fibroblastic cells derived from postmenopausal women produced stiffer matrices than 
Figure 1. Fibroblastic cells from postmenopausal prolapsed tissues deposit less extracellular matrix than 
controls, but with high collagen content. Cells derived from prolapsed tissues from premenopausal (POP-
pre) and postmenopausal (POP-post) women were cultured in vitro for five weeks in the presence of vitamin C 
and compared to controls. The deposited matrices were stained with Sirius red/fast green collagen staining kit 
(Chondrex Inc.) at different time points. Data represent the median (+ /− interquartile range) of five samples 
per group and is shown as: (A) total protein (control vs. POP-post: p = 0.0486), (B) collagen content, and  
(C) box plots of the percentage (%) of collagen content per total protein (control vs. POP-post at week 3, 
p = 0.0327; at week 4, p = 0.0400; and week 5, p = 0.0089). Differences between control and POP-post were 
identified by Kruskal-Wallis test followed by Dunn’s multiple comparison: *p < 0.05 and **p < 0.01.
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cells from non-prolapsed tissues with the effective Young modulus being 3 times higher. The same trend was seen 
in matrices deposited by cells from premenopausal women with prolapse (Table 1).
Collagen type I fibres and cell nuclei were aligned in one preferential direction in control and 
premenopausal POP groups but not in the postmenopausal POP group. One of the main compo-
nents of the ECM in the anterior vaginal wall is collagen I. Since the orientation of the collagen fibres influences 
the mechanical properties of the ECM27 we visualised the collagen I fibre alignment in the deposited matrices 
after five weeks of culture. Collagen type I fibres and cell nuclei were anisotropically aligned towards a preferential 
but unspecific direction in all matrices derived from control and premenopausal prolapsed cells (Fig. 2A,B). In 
contrast, 83% of the matrices derived from prolapsed postmenopausal cells had collagen fibres which appeared to 
have two anisotropically oriented layers (Fig. 2C).
The mature collagen cross-links hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP) were 
similar. Collagen molecules in POP tissues have been reported to have more mature cross-links than those 
from non-POP tissues9,17 and we wanted to investigate if this was the case in matrices deposited by vaginal cells 
in vitro. The high-performance liquid chromatography (HPLC) technique which was used can detect only the 
mature collagen cross-links hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP). After five weeks of culture, 
cells were freeze-thawed three times and post-incubated for an additional three weeks in PBS at 37 °C to allow 
the development of mature cross-links. No differences were seen in the amount of collagen cross-links within the 
deposited matrices (Table 2).
Proliferation of primary human anterior vaginal wall cells was not affected by prolapse nor 
by menopausal status. The quality and quantity of the deposited matrices can be affected by the type of 
cell, the number of cells and by their proliferation rate. We first characterised the initial population of primary 
fibroblastic cells by immunocytochemistry, and we confirmed that the studied cells were from the mesenchymal 
lineage (vimentin positive), at least 95% smooth muscle free (desmin negative), and negative for the endothelial 
cell marker Ulex Europaeus Agglutinin-I (UEA-1). These results were consistent with our previous report23. We 
also measured the total DNA of each cell type at the different time points during the five weeks of culture. Cells 
proliferated normally with a peak at week 4, and with almost no differences in cell number between weeks 4 and 
5 (Fig. 3). We found no differences in the proliferation rates of the studied groups.
Vaginal fibroblastic cells secreted matrix metalloproteinases-2 mainly in the active form and 
with peak secretion at week three. Tissue remodelling seems to be affected in tissues from patients 
with POP. To achieve a better understanding of tissue remodelling we detected secreted active, and inactive (pro 
form) matrix metalloproteinases (MMP) -2 and -9 by zymography. To correct for the difference in cell numbers 
at the different experimental time points, quantitative data was normalised to total DNA. Zymogram results show 
that most of the secreted enzymes were in the active form of MMP-2. In general, the amount of active MMP-2 
secreted by the cells increased from weeks one to three, except for prolapsed fibroblasts from premenopausal 
women (Fig. 4B), and decreased again at week four (Fig. 4A,C). No major differences were seen between weeks 
4 and 5. At the peak of secretion (week three) cells from postmenopausal women with prolapse released slightly 
higher amounts of active MMP-2 than control cells. At the same time point, cells from premenopausal women 
with prolapse secreted lower quantities of active MMP-2 than cells from the other two groups but the difference 
was not significant (Fig. 4). We were unable to detect MMP-9, and MMP-2 at week 0 was below detection levels 
(Supplementary Figure S1).
Altered matrix production by prolapsed fibroblasts was not a consequence of abnormal phe-
notypical changes towards the myofibroblastic lineage. It has been shown in vitro that when matrix 
stiffness is increased fibroblasts differentiate into myofibroblasts26. To find out whether the increased substrate 
stiffness of the prolapsed matrices was the result of a change in phenotype from fibroblasts to myofibroblasts, we 
detected the myofibroblastic marker α -smooth muscle actin (α -SMA) at the beginning of the experiments (week 
0), at the peak of protein deposition (week 3), and at the ending time point (week 5). Results showed a transient 
increase in myofibroblastic phenotype as α -SMA increased by week three, and thereafter were significantly lower 
from weeks three to five. There were no differences in cellular α -SMA protein content between the groups (Fig. 5 
and Supplementary Figure S2).
Discussion
Clinical studies have shown that in patients with cystocele, the prolapsed tissues have increased stiffness16,18–20, 
altered extracellular matrix composition8–17, and fibroblastic cells with lower contractile capacities21–23 and altered 
mechano-responses23,24. Our previous studies have shown that some of these differences seem to be acquired 
in some premenopausal Caucasian women with prolapse17,23, but the mechanisms behind these conditions are 
A Control 
(n = 5)
B POP-pre 
(n = 5)
C POP-post 
(n = 5)
A–B 
p-value
A–C 
p-value
B–C 
p-value
Young modulus (kPa) 16 (14.9–29.4) 26 (19.1–100.5) 50 (25.7–86.3) 0.3095 0.0317 0.5476
Table 1.  Surface micro-stiffness: effective Young modulus (kPa). Data is presented as: median (IQR). Non-
parametric statistical tests: Mann-Whitney.
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still unclear. Cells are responsible for tissue maintenance and remodelling. If matrix production is altered in 
prolapsed tissues, treatment outcomes could be improved by understanding the mechanisms behind the altered 
cell-matrix interactions. Our study has shown that cells from prolapsed anterior vaginal wall tissues produce 
Figure 2. Collagen type I fibres and cell nuclei were aligned in one preferential direction in 
control and premenopausal POP groups but not in the postmenopausal POP group. Representative 
immunohistochemistry micrographs of collagen I (green) and cells nuclei (blue) in deposited matrices after five 
weeks of culture of cells derived from (A) control, (B) prolapsed premenopausal (POP-pre), and (C) prolapsed 
postmenopausal (POP-post). The figure depicts the maximum intensity projection from z-stacks (top panel) 
and their corresponding fiber orientation (bottom panel). Images were acquired with 63 x objective of a Leica 
microscope. The bar is 50 μm.
Control (n = 5) POP-pre (n = 5) POP-post (n = 5)
(HP + LP)/triple helix 0.09 (0.08–0.25) 0.09 (0.04–0.10) 0.10 (0.10–0.12)
Table 2.  Biochemical analysis of collagen cross-links hydroxylysylpyridinoline (HP) and lysylpyridinoline 
(LP). Data is presented as: median (IQR). Non-parametric statistical tests: Mann-Whitney.
Figure 3. Proliferation of anterior vaginal wall fibroblastic cells was not affected by POP or menopausal 
status in vitro. The total DNA of fibroblastic cells was measured by CyQuant at different time points. The cells 
were derived from prolapsed tissues from premenopausal (POP-pre) and postmenopausal (POP-post) women, 
as well as from controls. The box plots correspond to five samples per group per time point. **p < 0.01 by 
Kruskal-Wallis test followed by Dunn’s multiple comparison compared to week 0. Week 0 vs. week 4: control, 
p = 0.0019; POP-pre, p = 0.0069; POP-post, p = 0.0011. Week 0 vs. week 5: control, p = 0.0019; POP-pre, 
p = 0.0031; POP-post, p = 0.0031. No differences were found between the study groups.
www.nature.com/scientificreports/
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Figure 4. Vaginal fibroblastic cells secreted and activated matrix metalloproteinases-2 in long term 
cultures in vitro. Conditioned media of fibroblastic cells from prolapsed premenopausal (POP-pre) (B) and 
postmenopausal (POP-post) (C) tissues was evaluated at different time points and compared to controls (A).  
Matrix metalloproteinase (MMP)-2 was detected by zymography, in samples derived from the same 
experiment, with gels processed in parallel. The blots were quantified by densiometry analysis of the bands 
and data were normalised to total DNA. The box plots correspond to five samples per group per time point. 
*p < 0.05 by Kruskal-Wallis test followed by Dunn’s multiple comparison. Week 3 vs. week 4: control, 
p = 0.0116; and POP-post, p = 0.0234. No differences were found between the study groups. Full-length gels are 
presented in Supplementary Figure S1.
Figure 5. Vaginal fibroblasts show transient differentiation to myofibroblasts in vitro. Cell lysates were 
collected at different time points (0, 3 and 5 weeks) and myofibroblast differentiation was detected by western 
immunoblotting of α -smooth muscle actin (α -SMA) and β -actin was used as a control. Cells originated from 
three groups: (A) controls, (B) prolapsed premenopausal (POP-pre), and (C) prolapsed postmenopausal (POP-
post). Samples derived from the same experiment were processed in gels in parallel. Blots were quantified by 
densiometry analysis of the bands and data was normalised to the first band of β -actin per blot. The box plots 
correspond to five samples per time point per group. **p < 0.01 by Kruskal-Wallis test followed by Dunn’s 
multiple comparison. Week 3 vs. week 4: control, p = 0.0056; POP-pre, p = 0.0066; POP-post, p = 0.0044 No 
differences were found between the study groups. Full-length blots are presented in Supplementary Figure S2.
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different extracellular matrices in vitro than cells derived from control tissues. The matrices deposited by cells 
from postmenopausal tissues were stiffer, with a high percentage of collagen, and with collagen I fibres with more 
than one preferred orientation. These data suggest that matrix production changed after cells had been exposed to 
prolapsed tissues and that the altered matrix production was more apparent in postmenopausal women. We also 
found no differences in the number of cells between the groups, thus confirming our previous observations and 
suggesting that the quality, and not the quantity, of the cells is responsible for the results23.
Several in vivo studies have shown that prolapsed tissues from women with POP are stiffer than controls16,18–20, 
which is in line with our in vitro findings. The reason for this increased stiffness in vivo remains unclear as results 
about the composition of the prolapsed matrix have been different and sometimes contradictory28,29. The amount 
of collagen cross-links might play an important role as they have a big influence on the mechanical properties of 
tissues27, and they have been reported to be increased in prolapsed tissues9,17. The values of the mature cross-links 
that we found in our matrices were below the values that have been reported in tissues17, indicating that the 
formation of mature collagen cross-links in our in vitro experiments was still premature. It is also important to 
note that the formation of mature collagen cross-links might be different in vivo from in vitro. The increased 
stiffness that we found in the POP matrices in vitro is likely to be a consequence of the high percentage of col-
lagen present and the structural difference found in the collagen I fibres. Matrix production from vaginal cells 
derived from prolapsed tissues was lower than those from controls, but with a high percentage of collagen fibres. 
The same trend was seen in matrices from premenopausal women with POP suggesting that the premenopausal 
status seems to ameliorate, and not reverse the adverse cellular defects in prolapsed tissues. The collagen I fibres 
found in the deposited matrices had anisotropic orientation that seems to be an intrinsic ordering principle, 
since no external forces were applied to the system and there were no physical constraining boundaries. This 
self-organization might be due to the spontaneous self-organization of the high density of collagen, and to the 
cells’ producing and arranging the fibres within the matrix or a combination of both27. The fact that the stiffer 
matrices derived from postmenopausal prolapsed cells appeared to have collagen I fibres with two anisotropically 
oriented layers, remains intriguing.
During wound tissue repair, fibroblasts are recruited to the site of injury and they can differentiate into myofi-
broblasts. When myofibroblasts appear, the remodelling phase starts and the granulose tissue is replaced by a 
scar tissue rich in collagen I30. In this study we used primary fibroblastic cells, i.e. fibroblasts and myofibroblasts. 
Fibroblasts can differentiate into myofibroblasts due to various stimuli including matrix stiffness26. When cells 
produce the proper matrix, tension in their micro-environment can be released and myofibroblasts should dis-
appear either due to apoptosis or to their dedifferention back into fibroblasts26. If the mechanical tension of 
the micro-environment is not released, myofibroblasts might not disappear, making stiffer matrices and caus-
ing a continuous imbalance in tissue remodelling, a common feature in fibrotic tissues26,31. In our experiments 
we found a transient myofibroblast differentiation with peak expression of the cellular myofibroblast marker 
α -smooth muscle actin (α -SMA) at week three that coincided with the peak of matrix deposition and with the 
peak of secretion and activation of matrix metalloproteinase-2 (MMP-2). The peak of activation of MMP-2 found 
in cells from the controls, and from the postmenopausal POP group, was not evident in cells from premenopausal 
POP women, even though the maximum matrix deposition and myofibroblast differentiation was still found at 
week three. Therefore, we speculate that the peak of MMP-2 activation of cells from premenopausal POP women 
occurred before week three, but this should be further confirmed. Regardless of this variation, it is reasonable to 
say that the peak of remodelling occurred at week three. These results are in line with normal tissue repair process 
where myofibroblasts secrete the new matrix, MMPs and tissue inhibitor of matrix metalloproteinases (TIMPs) to 
remodel the granulose tissue30. However, no differences were found between the study groups, and myofibroblasts 
seemed to disappear after the peak in matrix remodelling. Therefore, the altered matrix production does not seem 
to be a consequence of abnormal phenotypical changes towards the myofibroblastic lineage.
It has been hypothesised that the weakening of the prolapsed tissues is a consequence of the increased enzy-
matic activity, particularly of MMP-2 and MMP-99–11. In our in vitro experiments we did not find an increase 
of MMP-2 enzymatic activity in fibroblastic prolapsed cells compared to controls. There are several possible 
explanations for the discrepancies between in vivo and in vitro observations of MMP activity: (i) other cells are 
responsible for the excessive in vivo enzymatic activity, (ii) mechanical loading induces MMP secretion and acti-
vation23,24,32 (our in vitro model was under static conditions), (iii) the differences occurred at time points other 
than the studied times, (iv) the experiments were performed on substrates which were different to the native 
micro-environments. In the present study we focused on total fibrillar collagen production and remodelling. 
However, characterizing the exact composition of the deposited matrices and correlating that information to the 
mechanical properties would be an interesting topic for a future study involving proteomics.
In summary, affected fibroblasts from postmenopausal prolapsed tissues produced altered matrices in vitro 
compared to controls. Similarly to normal wound repair, there was a transient increase in myofibroblastic pheno-
type that was lost after the peak of tissue remodelling. The altered matrix production in prolapsed tissues does not 
appear to be a consequence of abnormal phenotypical changes towards the myofibroblastic lineage.
Methods
Patient selection, tissue processing, and cell isolation. Patients were recruited from three hospitals 
in the Netherlands: Kennemer Gasthuis Hospital in Haarlem, VU University Medical Centre, and the Boerhaave 
Medical Centre in Amsterdam. After informed consent was obtained from all patients and according to institu-
tional guidelines, biopsies were collected from three groups of Caucasian women. A control group of five women 
undergoing hysterectomy for benign gynaecological reasons, and two groups of women undergoing prolapse 
surgery (POP-Q stages ≥ II): five premenopausal women (POP-pre), and five postmenopausal women (POP-
post). Women were non-smokers with similar parity and similar POP-Q cystocele stages in POP cases (Table 3). 
Exclusion criteria were previously described17. The tissues collected in the present study were waste material after 
www.nature.com/scientificreports/
7Scientific RepoRts | 6:22971 | DOI: 10.1038/srep22971
surgery and not subject to Ethical Committee approval. Full thickness (1 cm2) vaginal wall tissue biopsies were 
taken from the pericervical region of the anterior vaginal cuff after hysterectomy in the controls, and from the 
prolapsed vaginal wall in the POP cases. A total of 15 different vaginal primary fibroblastic cells were isolated 
within 24 hours of tissue extraction and cultured using enzymatic digestion as previously described24. Cells were 
grown in an incubator at 37 °C, 95% humidity and 5% CO2, with culture medium: Dulbecco’s modified Eagle’s 
medium-DMEM (Gibco-Life technologies, Paisley, UK) supplemented with 10% foetal bovine serum (FBS; 
HyClone, South Logan, UT, USA), 100 μg/ml streptomycin, 100 U/ml penicillin, and 250 μg/ml amphotericin-B 
(Sigma-Aldrich, St. Louis, MO, USA). The cells used in this study were from passages two to four and were at least 
94% viable. The initial population of primary cells was characterized by immunocytochemistry analysis as pre-
viously described23, with markers for mesenchymal cells (vimentin; DakoCytomation, Copenhagen, Denmark), 
smooth muscle cells (Desmin; DakoCytomation), and endothelial cells (Ulex Europaeus Agglutinin I; Vector 
Laboratories, Burlingame, CA, USA).
In vitro matrix production. The extracellular matrix produced over five weeks by human vaginal primary 
cells was evaluated for different outcome parameters in vitro. Following the manufacturer’s instructions, cells 
were counted using the Muse® count & viability assay kit with the Muse® cell analyzer system (Merck Millipore, 
Darmstadt, Germany). Cells were cultured with culture media and a seeding density of 10,000 cells/cm2  
in plastic tissue-culture plates and analysed at different time points: 24 hours (0W), 1 weeks (1W), 3 weeks (3W) 
and 5 weeks (5W). After 24 hours, cells were synchronized for 1 hour at 5 °C, and 0W plates were processed as 
follows: to detect released matrix metalloproteinases (MMPs)-2 and -9, media was replaced by culture media 
containing 1% FBS (HyClone) and post-incubated for 6 hours in an incubator at 37 °C, 95% humidity and 5% 
CO2. Conditioned media was saved for zymogram analysis and cell lysates were collected for total DNA analysis. 
Samples were also prepared for total fibrillar collagen content.
The rest of the cultures were refreshed with culture media supplemented with 50 μg/ml vitamin C 
(Sigma-Aldrich), and thereafter refreshed every 3 to 4 days with the same medium. After each time point, samples 
were processed as at 0W. Additionally, samples were collected at 0W, 3W, and 5W for western immunoblotting. At 
5W, samples were also collected for surface micro-stiffness, collagen I immunostaining and biochemical analysis 
(see relevant sections below).
Zymogram analysis of secreted MMP-2 and MMP-9. Secreted MMP-2 and MMP-9 were detected by 
zymography following the manufacturer’s protocol for Novex zymogram gels (10% zymogram gelatin gel, Life 
Technologies). The dark bands of gelatinolytic activity were visualized with the eStain protein staining device 
(GeneScript, Piscataway, NJ, USA). Images were acquired with the Biospectrum AC Imaging System (UVP, 
Cambridge, UK) and zymogram quantification of the density of the bands was performed using Image J 1.44p 
software (National Institutes of Health, USA).
Total DNA analysis. Fibroblastic cells were seeded on 48-well plates and samples were collected at different 
time points: 0, 1, 3, 4 and 5 weeks. At the end of each time point, cells were washed with PBS, and 300 μl/well of 
milliQ water was added before samples were stored at −20 °C until further analysis. After three freeze and thaw 
cycles, total DNA of duplicate samples was measured with the CyQuant cell proliferation assay kit according to 
the manufacturer’s specifications (Molecular Probes Inc., Life Technologies). Fluorescence was measured using 
the SynergyTMHT multi-mode microplate reader (Biotek Instruments Inc.).
Detection and quantification of fibrillar collagens and non-collagenous proteins. The total pro-
tein content, and the fibrillar collagen content of the deposited matrices, was measured with the Sirius red/fast 
green collagen staining kit (Chondrex Inc., Redmond, USA) following the manufacturer’s specification. The opti-
cal density values (OD) of eluted dye were measured at 540 nm and 605 nm with the SynergyTMHT multi-mode 
microplate reader (Biotek Instruments Inc.). Calculations were made with the formulas: total protein = {[OD540 −  
(OD605 × 0.291)]/0.0378} + OD605/0.00204; collagen = [OD540 − (OD605 × 0.291)]/0.0378.
Western immunoblotting. Cells cultured on 6-well plates were lysed with 700 μl/well of Lysis-M buffer 
including proteinase inhibitor (Roche Diagnostics GmbH, Mannheim, Germany). Protein content was deter-
mined using the Pierce BCA Protein Assay kit following the manufacturer’s instructions (Thermo Scientific, 
Rockford, USA). Equal amounts of protein were denatured and separated by electrophoresis on a Bolt® 4–12% 
Bis-Tris Plus gel under reducing conditions and transferred to iBlot® PVDF membrane (Life Technologies). 
Blots were blocked for 1 hour at room temperature with a blocking buffer (PBS with 0.5% Tween-20 and 1% 
bovine serum albumin; Sigma-Aldrich), then incubated with anti-α -SMA monoclonal antibody (clone 1A4, 
DakoCytomation) diluted 1:500 in blocking buffer for 1 hour at room temperature and subsequently overnight 
at 4 °C. Bound antibodies were visualized with a horseradish peroxidase-conjugated antibody goat anti-mouse 
Characteristic
A Control 
(n = 5)
B POP-pre 
(n = 5)
C POP-post 
(n = 5)
A–B 
p-value
A–C 
p-value
B–C 
p-value
Agea 47.0 ± 4.12 44.6 ± 4.93 59.4 ± 9.34 0.528 0.056 0.032
Parityb 3 (1–3) 2 (2–3) 2 (2–3) 0.913 0.914 1.000
POP-Q cystocele stageb 0 (0) 2 (2) 2 (2–3.5)
Table 3.  Patient characteristics. Data is presented as: mean ± SDa, or median (IQR)b. Non-parametric 
statistical tests: Mann-Whitney.
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(1:10,000) and the Supersignal west pico chemiluminescence kit (Thermo Scientific). Images were acquired with 
the Biospectrum AC Imaging System (UVP). Gamma settings were optimized for band clarity. After detection, 
blots were washed with blocking buffer, incubated for 1 hour at room temperature with mouse anti-β -actin anti-
body (1:5,000; Sigma-Aldrich), and washed three times with PBS. To visualize the bound antibodies with alkaline 
phosphatase (AP) chromogenic detection blots were washed for 10 minutes at room temperature with Tris Buffer 
Saline pH 7 (TBS: 0.1M tris with 0.9% NaCl; Sigma-Aldrich), then washed for 10 minutes with AP buffer pH 
9.5–10 (100 mM NaCl, 0.1 M HCl and 5 mM MgCl2; Sigma-Aldrich), and detected with NBT/BCIP substrate 
(Roche diagnostics GmbH) diluted in AP buffer (1:100). Images were acquired with the Biospectrum AC Imaging 
System (UVP). Quantification of the band density was performed using Image J 1.44p software (NIH).
Surface micro-stiffness. The mechanical properties of the deposited matrices were measured using a 
newly-developed nano-indentor designed to test the surface stiffness of biological tissues (PIUMA, Optics11, 
Amsterdam, The Netherlands). After five weeks of culture two fresh samples were indented in PBS with the 
PIUMA device and according to supplier’s instructions (Optics11). We used a soft cantilever on the top of a fer-
ruled optical fibre33,34 with a radius of 88 μm and a stiffness of 0.85 N/m. The indentations were depth controlled 
(15 μm) and the loading and unloading periods were set to 3 seconds. Based on the load and displacement curves, 
the effective Young’s modulus was automatically calculated by the software from the PIUMA (Optics11). To cali-
brate the probe and the measurement technique, a stiff surface was used before each series of tests.
Collagen I immunostaining. Matrices deposited after five weeks of culture were fixated using 4% formal-
dehyde, then incubated with blocking buffer (1% BSA, 20% donkey serum, PBS) for 1 hour followed by 2 hours 
incubation with rabbit polyclonal anti-collagen type I antibody (1:1000, Abcam, USA) at room temperature. 
After three washings with PBS, Alexa 488 donkey anti-rabbit (1:2000, Invitrogen, USA) was added for 1 hour. 
Then the slides were washed three times in PBS and mounted with Vectashield mounting medium containing 
DAPI (Vector Laboratories, USA). Images were taken using an inverted confocal microscope (Leica SP8, Leica, 
Germany). To evaluate the local fibre orientation we used Orientation J which is an Image J plug-in (NIH) and 
calculates the local orientation of fibres in every pixel of the image.
Biochemical analysis of the collagen cross-links hydroxylysylpyridinoline (HP) and lysylpyridi-
noline (LP). Cells were cultured for five weeks on 6-well plates and then freezed-thawed three times. To allow 
time for the maturation of collagen cross-links, the acellular matrices were post-incubated for three more weeks 
in PBS at 37 °C. Collagen and the mature collagen cross-links hydroxylysylpyridinoline (HP) and lysylpyridino-
line (LP) were measured biochemically with a HPLC system equipped with online sample purification on CC31 
cellulose using a Prospekt solid-phase extractor (Separations, Jasco Benelux BV, IJsselstein, The Netherlands) as 
previously described17. The mature collagen cross-links were expressed as (HP + LP)/triple helix.
Statistics. Data are expressed as the median with the interquartile range (IQR) of five independent samples 
per group. Analyses were performed with Prism software version 6.0 (GraphPad Software Inc., San Diego, CA, 
USA) using non-parametric Kruskal-Wallis test followed by Dunn’s multiple comparisons for the grouped anal-
ysis or Mann-Whitney test for paired analysis. Differences were considered significant at 5% level (p < 0.05).
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